192 related articles for article (PubMed ID: 22873658)
1. Benefits of using magnesium sulphate (MgSO₄) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria.
Okereke E; Ahonsi B; Tukur J; Ishaku SM; Oginni AB
BMC Res Notes; 2012 Aug; 5():421. PubMed ID: 22873658
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.
Tukur J; Ahonsi B; Ishaku SM; Araoyinbo I; Okereke E; Babatunde AO
Matern Child Health J; 2013 Sep; 17(7):1191-8. PubMed ID: 22956402
[TBL] [Abstract][Full Text] [Related]
3. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
[TBL] [Abstract][Full Text] [Related]
4. Management of eclampsia at AKTH: before and after magnesium sulphate.
Tukur J; Muhammad Z
Niger J Med; 2010; 19(1):104-7. PubMed ID: 20232764
[TBL] [Abstract][Full Text] [Related]
5. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
Tukur J
Ann Afr Med; 2009; 8(2):76-80. PubMed ID: 19805935
[TBL] [Abstract][Full Text] [Related]
6. Introduction of an innovation for the reduction of maternal mortality in Kano State, northern Nigeria: a case study of magnesium sulphate.
Tukur J; Ogedengbe C; Nwanchukwu E; Araoyinbo IA; Yakasai IA; Adaji SE; Ajala B
Trop Doct; 2011 Oct; 41(4):197-200. PubMed ID: 21831930
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.
Oguntunde O; Charyeva Z; Cannon M; Sambisa W; Orobaton N; Kabo IA; Shoretire K; Danladi SE; Lawal N; Sadauki H
BMC Pregnancy Childbirth; 2015 Jun; 15():130. PubMed ID: 26037906
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome in eclamptics at the University of Abuja Teaching Hospital, Gwagwalada, Abuja: a 3 year review.
Agida ET; Adeka BI; Jibril KA
Niger J Clin Pract; 2010 Dec; 13(4):394-8. PubMed ID: 21220852
[TBL] [Abstract][Full Text] [Related]
9. Ecalmpsia: maternal and fetal outcome.
Jido TA
Afr Health Sci; 2012 Jun; 12(2):148-52. PubMed ID: 23056020
[TBL] [Abstract][Full Text] [Related]
10. Training health workers for magnesium sulfate use reduces case fatality from eclampsia: results from a multicenter trial.
Okonofua FE; Ogu RN; Fabamwo AO; Ujah IO; Chama CM; Archibong EI; Onah HE; Galadanci HS; Akuse JT
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):716-20. PubMed ID: 23550632
[TBL] [Abstract][Full Text] [Related]
11. Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice.
Bigdeli M; Zafar S; Assad H; Ghaffar A
PLoS One; 2013; 8(3):e59158. PubMed ID: 23555626
[TBL] [Abstract][Full Text] [Related]
12. Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work?
Goldenberg RL; Jones B; Griffin JB; Rouse DJ; Kamath-Rayne BD; Trivedi N; McClure EM
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):148-55. PubMed ID: 25353716
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of intramuscular loading dose of MgSO4 in severe pre-eclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
Okusanya BO; Garba KD; Ibrahim HM
Niger Postgrad Med J; 2012 Jun; 19(2):77-82. PubMed ID: 22728971
[TBL] [Abstract][Full Text] [Related]
14. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.
Lancet; 1995 Jun; 345(8963):1455-63. PubMed ID: 7769899
[TBL] [Abstract][Full Text] [Related]
15. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
Ridge AL; Bero LA; Hill SR
BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
[TBL] [Abstract][Full Text] [Related]
16. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries.
Goldenberg RL; McClure EM; Macguire ER; Kamath BD; Jobe AH
Int J Gynaecol Obstet; 2011 May; 113(2):91-5. PubMed ID: 21349517
[TBL] [Abstract][Full Text] [Related]
17. Maternal and perinatal outcome of eclampsia over a decade at a tertiary hospital in Kuwait.
Chibber R; Al-Hijji J; Amen A; Fouda M; Kaleemullah ZM; El-Saleh E; Mohammed AT
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3132-7. PubMed ID: 26616117
[TBL] [Abstract][Full Text] [Related]
18. Maternal mortality associated with eclampsia and severe preeclampsia of pregnancy.
Sawhney H; Aggarwal N; Biswas R; Vasishta K; Gopalan S
J Obstet Gynaecol Res; 2000 Oct; 26(5):351-6. PubMed ID: 11147722
[TBL] [Abstract][Full Text] [Related]
19. Magnesium sulphate: a life saving drug.
Thapa K; Jha R
JNMA J Nepal Med Assoc; 2008; 47(171):104-8. PubMed ID: 19079372
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
Eddy KE; Vogel JP; Zahroh RI; Bohren MA
BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
